Clinical Trials Sponsored by Pilipili NV

Total 334 results

University Hospital, Ghent
Pilipili NV; Imec

Completed

EEG@HOME (Phase 3a of the Project, Comparison of EEG-recordings)

Epilepsy

Belgium
University Hospital, Ghent
Pilipili NV; Imec

Terminated

EEG@HOME (Phase 3b of the Project, Interviews)

Epilepsy

Belgium
University Hospital, Ghent
Pilipili NV; Imec

Completed

EEG@HOME (Phase 2 of the Project, Measurements in Healthy Volunteers)

Epilepsy

Belgium
University Hospital, Ghent
Pilipili NV; Imec

Completed

EEG@HOME (Phase 1 of the Project)

Epilepsy

Belgium
University Hospital, Ghent
Universitaire Ziekenhuizen KU Leuven; Pilipili NV; Imec

Withdrawn

EEG@HOME (Phase 4 of the Project)

Epilepsy

Belgium
Qompium NV

Recruiting

Combining Accelerometer, Gyroscope, Sound, Electrocardiography and Photoplethysmography Data in Cardiac Monitoring (CARDS-pilot)

Atrial Fibrillation

Belgium
Galapagos NV

Recruiting

Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)

Juvenile Idiopathic Arthritis

Spain, Germany, United Kingdom, France, Poland
Galapagos NV

Recruiting

A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus (GALACELA)

Systemic Lupus Erythematosus

United States, Spain, Bulgaria, France, Georgia, Germany, Puerto Rico, Argentina, Poland, Hungary, Chile, Peru
Barco NV

Recruiting

Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer (DermScan)

Skin Diseases | Skin Cancer

Belgium
Galapagos NV

Active, not recruiting

Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis (FILOSOPHY)

Rheumatoid Arthritis

Belgium, Netherlands, Spain, Germany, Italy, United Kingdom
Oystershell NV

Completed

Efficacy of a Cryogenic Medical Device on Skin Tags Versus a Comparator Product.

Skin Tags

France
Galapagos NV

Terminated

A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission (CAPYBARA)

Ulcerative Colitis

United States, Germany, Korea, Republic of, Spain, France, Hungary, United Kingdom, Poland, Belgium, Czechia, Italy, South Africa, Taiwan
Galapagos NV

Completed

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative Colitis (SEA TURTLE)

Ulcerative Colitis

Ukraine, Georgia, Poland, Moldova, Republic of
Ectosense NV

Active, not recruiting

A Validation Study of the NightOwl Home Sleep Apnea Test

Sleep Apnea

United States
Galapagos NV

Terminated

A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care (ISABELA1)

Idiopathic Pulmonary Fibrosis

United States, Spain, Japan, Belgium, Taiwan, Denmark, Germany, United Kingdom, Greece, Australia, Czechia, Brazil, Chile, Peru, Turkey
Galapagos NV

Terminated

A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care (ISABELA2)

Idiopathic Pulmonary Fibrosis

United States, Netherlands, Korea, Republic of, Israel, Japan, New Zealand, France, Italy, Argentina, Germany, Hungary, South Africa, Poland, Canada, Mexico
Galapagos NV

Completed

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate (LADYBUG)

Rheumatoid Arthritis

Ukraine, Georgia, Bulgaria, Poland
Oystershell NV

Completed

A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.

Head Lice | Pediculosis Capitis

United States
Galapagos NV

Completed

Evaluation of Mass Balance and Absolute Bioavailability of GLPG3667

Healthy

United Kingdom
Galapagos NV

Completed

A Study to Evaluate How Well Single and Multiple Doses of GLPG4399 Are Tolerated in Healthy, Adult Subjects

Healthy

Canada
Galapagos NV

Completed

A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) (PINTA)

Idiopathic Pulmonary Fibrosis

Slovakia, Finland, France, Sweden, Bulgaria, Croatia, Oman, Romania, Ukraine
Galapagos NV

Completed

Evaluation of Mass Balance and Absolute Bioavailability of GLPG3970

Healthy

United Kingdom
Oystershell NV

Completed

Clinical Evaluation of Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis

Onychomycosis of Toenail

Tunisia
Galapagos NV

Completed

Evaluation of Mass Balance and Absolute Bioavailability of GLPG1205

Healthy

United Kingdom
Galapagos NV

Completed

Drug-drug Interaction Study With GLPG3667 and Midazolam in Healthy Subjects

Healthy

United Kingdom
Galapagos NV

Terminated

A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis (GECKO)

Atopic Dermatitis

United States
Galapagos NV

Completed

A Study Investigating the Safety, Absorption and Elimination of GLPG3312, a New Drug in the Treatment of Inflammatory Diseases

Healthy

Netherlands
Qompium NV

Completed

The Validation of the FibriCheck Application for the Detection of Atrial Fibrillation (FLASH-AF)

Atrial Fibrillation

Belgium
Galapagos NV

Completed

A Study in Healthy Male Volunteers to Test How the Test Medicine GLPG1972 is Taken up by the Body When Given by Mouth and Into the Vein as an Injection

Healthy

United Kingdom
Galapagos NV

Completed

A Study to Evaluate the Effects of a Single and Multiple Oral Doses of GLPG3121 in Adult, Healthy, Male Subjects

Healthy

Belgium
Galapagos NV

Completed

A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737 in Patients With Cystic Fibrosis. (FALCON)

Cystic Fibrosis

Belgium, Bulgaria, Germany, Greece, Netherlands, Serbia, Sweden, United Kingdom
Galapagos NV

Completed

A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG3067 in Healthy Subjects.

Healthy

Belgium
Oystershell NV

Completed

A Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice

Head Lice

United States
FLUIDDA nv

Completed

Evaluation With Scans and Pharyngometry of the Possible Changes in Upper Airway Geometry Induced by Using Different Mouthpieces.

Influence of Mouthpiece Design on Upper Airway Geometry

Belgium
Oystershell NV

Completed

Clinical Evaluation of the Efficacy of a Medical Device in Treatment of Toenail Onychomycosis

Onychomycosis

Tunisia
Oystershell NV

Completed

Clinical Study : Efficacy and Safety of Three Cryotherapy Devices for Wart Treatment

Warts
Galapagos NV

Completed

A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2451 in Healthy Male Subjects

Healthy

Belgium
Galapagos NV

Completed

This is a Study to Evaluate the Effect of Aging of Multiple Doses of GLPG1205 in Healthy Subjects

Healthy | Elderly

Belgium
FLUIDDA nv

Completed

Transplant Optimization Using Functional Imaging (TROFI) (TROFI_BE)

Bronchiolitis Obliterans | Lung Transplant Rejection

Belgium
Novosanis NV

Completed

Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID (POC_VAX-ID)

Hepatitis B

Belgium
Galapagos NV

Completed

First-in-Human Single and Multiple Dose of GLPG1972

Healthy

Belgium
Galapagos NV

Completed

First-in-Human Single and Multiple Dose of GLPG2222

Healthy

Belgium
FLUIDDA nv

Withdrawn

The Comparison of Electronic Auscultation Coupled With CALSA and FRI; Repeatability of FRI Biomarkers

Asthma

Belgium
Galapagos NV

Completed

A Phase I, Open Interaction Study Between GLPG1837 and Midazolam in Healthy Male Subjects

Healthy

Belgium
Novosanis NV

Completed

Echographic Measurement of Skin Thickness

Skin Thickness

Belgium
FLUIDDA nv

Completed

Research to Evaluate a Possible Relation Between Values Obtained After Processing CT Images, Lung Function Tests and the Experience of the Patient During an Exacerbation in COPD Patients.

Pulmonary Disease, Chronic Obstructive

Netherlands, Belgium, Italy
Galapagos NV

Completed

Oral Bioavailability of Solid Formulation of GLPG1205 With and Without Food

Healthy

Belgium
Galapagos NV

Completed

First-in-Human Single and Multiple Dose of GLPG1205

Healthy

Belgium
Galapagos NV

Completed

Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Hungary, Moldova, Republic of, Russian Federation, Ukraine
Galapagos NV

Completed

Investigation of the Pharmacokinetics and Metabolism of GLPG0634 in Healthy Male Subjects

Healthy

United Kingdom

3

Subscribe